Carried out as part of the National Cancer Plan 2
Online questionnaire
Supported by the Ministry of Health
Welcome to Colive Cancer!
Want to know more about Colive Cancer? Watch this explanatory video about the study!
Why participate in Colive?
Who can participate in Colive Cancer?
The Colive Cancer study concerns any adult (above 18) who has been treated for cancer in Luxembourg in the last 5 years (from 01/01/2018 onwards).
How to participate in Colive Cancer?
Go to: Colive Cancer
Using a computer, tablet, or smartphone select the following link: Colive Cancer.
Give your consent
Before accessing the questionnaire, you will need to read and electronically sign an informed consent form. You can then download a copy if you wish.
Information about the study will remain available on this site, via the tab: “Informatives notices“.
Complete the questionnaire directly online
The questionnaire is divided into 7 modules, and focuses on the different aspects of the cancer journey. Depending on your profile, it should take you an average of 20 to 40 minutes to fill it.
Participate immediately by clicking on the button below
Some important information before participating:
- The questionnaire is to be completed only once and if possible on one go. It should take you an average of 20 to 40 minutes to fill it.
- The survey is designed in the form of a self-administered questionnaire, so that it can be completed autonomously and individually. However, if you encounter difficulties in filling it out and you have the opportunity to be assisted by a relative or friend, don´t hesitate to ask for help, but always referring to your own experience.
- At the end of the questionnaire, you will be invited to participate in recordings of your voice. These voice recordings will then be analyzed to investigate potential links between specific voice features and the cancer disease (symptoms, side effects, etc.).
This section is completely optional and is not part of the Colive Cancer study.
Testimonials and support for Colive Cancer
“This patient-centred approach will allow us, for the first time in Luxembourg, to identify what works well, and also perhaps more importantly, what to improve on in the National Cancer Plan”
